The ITV doctor told Instagram followers obesity is driven by biology, not willpower, and his followers shared their own Mounjaro stories in reply.
Recap by typeshit. Full story at The Mirror.
An investing platform's company history runs from Lilly's 1876 founding through Humulin and Prozac to its obesity drug boom. Background, not news.
Generic advice that a lack of hunger doesn't mean you've eaten enough, with a nudge toward smaller portions built around protein.
Dr. Mimi Tan points to a wider set of obesity treatments and notes Ozempic is the semaglutide brand meant for type 2 diabetes.
Brian Underwood shares that the Men's Health fall issue starring Drake Maye is on newsstands, with peptides among the topics inside.
Drugs.com
A UC San Diego trial of 166 teens found 22% held their loss a year later with mood training, versus 4% with standard counseling. No drugs involved.
Lynette Ntuli posts about a risk she says doctors flag for type 2 diabetics taking Ozempic. The text is cut off, so see her full post for details.
Loading…